ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Mitsubishi Tanabe Pharma to step up US drug sales

OSAKA -- Mitsubishi Tanabe Pharma will spend more than 200 billion yen ($1.61 billion) over the five years ending fiscal 2020 to expand new-drug sales in the American market under a medium-term business plan announced Monday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more